Literature DB >> 26308152

Genetic analysis of SLC41A1 in Chinese Parkinson's disease patients.

Ling Wang1, Lan Cheng1, Nan-Nan Li1, Wen-Juan Yu1, Xiao-Yi Sun1, Rong Peng1.   

Abstract

Sequence variants in SLC41A1 (solute carrier family 41 member 1) within the PARK16 locus have been reported to be associated with Parkinson's disease (PD). We performed direct DNA sequencing of the SLC41A1 gene in 100 early-onset PD cases. A novel intron variant (NM_173854.5:c.993-90delA) and a known synonymous-coding variant (NM_173854.5:c.339 C>T, causing p.Thr113Thr, rs11240569) were identified in the SLC41A1 gene. Then we genotyped the rs11240569 variant in a total of 2237 Han Chinese comprising of 1063 sporadic PD and 1174 controls to investigate the association with risk of PD, we also conducted further stratified analysis according to age at onset and compared the clinical characteristics of CC + CT subjects with TT subjects. In this study, we confirmed that the C allele of SLC41A1 (rs11240569) polymorphism reduces the risk to develop sporadic PD (P = 0.018). Additionally, subjects with CC + CT genotypes have a reduced risk compared to those with TT genotype (P = 0.022), the association was modestly seen among the younger age group (P = 0.05), but was not significant among the older age group (P = 0.641). Besides, we demonstrated that CC + CT subjects cannot be distinguished from TT subjects based on their clinical features. Our study, the first demonstrates that SLC41A1 (rs11240569) is associated with a lower risk of PD in a Han Chinese population from mainland China.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  Parkinson's disease; SLC41A1; rs11240569; variations

Mesh:

Substances:

Year:  2015        PMID: 26308152     DOI: 10.1002/ajmg.b.32365

Source DB:  PubMed          Journal:  Am J Med Genet B Neuropsychiatr Genet        ISSN: 1552-4841            Impact factor:   3.568


  6 in total

1.  SLC41A1 and TRPM7 in magnesium homeostasis and genetic risk for Parkinson's disease.

Authors:  Morgan Sturgeon; Perry Wu; Robert Cornell
Journal:  J Neurol Neuromedicine       Date:  2016-12-30

2.  Genetic Analysis of the ZNF512B, SLC41A1, and ALDH2 Polymorphisms in Parkinson's Disease in the Iranian Population.

Authors:  Faranak Madadi; Mahmoud Shekari Khaniani; Ehsan Esmaili Shandiz; Hormoz Ayromlou; Safa Najmi; Babak Emamalizadeh; Shaghayegh Taghavi; Javad Jamshidi; Abbas Tafakhori; Gholam-Ali Shahidi; Hossein Darvish
Journal:  Genet Test Mol Biomarkers       Date:  2016-09-09

3.  Associations of rs823128, rs1572931, and rs823156 polymorphisms with reduced Parkinson's disease risks.

Authors:  Ye Bai; Lihong Dong; Xinghua Huang; Shuanglin Zheng; Ping Qiu; Fenghua Lan
Journal:  Neuroreport       Date:  2017-09-27       Impact factor: 1.837

4.  Magnesium transporter protein solute carrier family 41 member 1 suppresses human pancreatic ductal adenocarcinoma through magnesium-dependent Akt/mTOR inhibition and bax-associated mitochondrial apoptosis.

Authors:  Jing Xie; Chien-Shan Cheng; Xiao Yan Zhu; Ye Hua Shen; Li Bin Song; Hao Chen; Zhen Chen; Lu Ming Liu; Zhi Qiang Meng
Journal:  Aging (Albany NY)       Date:  2019-05-08       Impact factor: 5.682

5.  Alzheimer's Disease-Associated SNP rs708727 in SLC41A1 May Increase Risk for Parkinson's Disease: Report from Enlarged Slovak Study.

Authors:  Michal Cibulka; Maria Brodnanova; Marian Grendar; Jan Necpal; Jan Benetin; Vladimir Han; Egon Kurca; Vladimir Nosal; Matej Skorvanek; Branislav Vesely; Andrea Stanclova; Zora Lasabova; Zuzana Pös; Tomas Szemes; Stanislav Stuchlik; Milan Grofik; Martin Kolisek
Journal:  Int J Mol Sci       Date:  2022-01-29       Impact factor: 5.923

6.  SNPs rs11240569, rs708727, and rs823156 in SLC41A1 Do Not Discriminate Between Slovak Patients with Idiopathic Parkinson's Disease and Healthy Controls: Statistics and Machine-Learning Evidence.

Authors:  Michal Cibulka; Maria Brodnanova; Marian Grendar; Milan Grofik; Egon Kurca; Ivana Pilchova; Oto Osina; Zuzana Tatarkova; Dusan Dobrota; Martin Kolisek
Journal:  Int J Mol Sci       Date:  2019-09-21       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.